In Maryland, Intrexon Corporation has entered into a collaboration with FuturaGene Group, a subsidiary of Suzano Papel e Celulose S.A., the second largest producer of eucalyptus pulp in the world. The collaboration aims to increase biomass in eucalyptus and poplar trees. This collaboration will utilize Intrexon’s platform to design complex, innovative gene constructs and FuturaGene’s […]
Second Product of Intrexon’s Proprietary Bioconversion Platform Following Isobutanol Who’s happy, who’s bumming — and how far along is the work, really? The Digest looks at Intrexon’s breakthrough. Gas-to-Liquids approach significantly more cost-efficient versus conventional methods, company says. In California, Intrexon announced the bioconversion of methane to farnesene in the lab with its proprietary platform. Farnesene […]
Biobased investing continues surging, both direct and via strategics. The Digest has the data and the scoop in our 5-Minute Guide. In Florida, Biofuels Digest reports that 9 biobased ventures raised $363.8 million in new capital in 2013, compared to $435 million in Q2, and $434 million in Q4 2012 and Q1 2013. Overall, the […]
In Maryland, Intrexon Corporation today announced the pricing of its initial public offering of 9,999,999 shares of common stock at a public offering price of $16.00 per share, before underwriting discounts and offering expenses. All of the common stock is being offered by Intrexon. The shares are expected to begin trading on the New York […]
In California, Amyris announced the appointment of R. Neil Williams, Chief Financial Officer of Intuit, as a member of Amyris’s Board of Directors and the Chair of the Audit Committee. Williams has been Senior Vice President and Chief Financial Officer of Intuit since January 2008. Before joining Intuit, Williams was the Executive Vice President and […]
In California, Intrexon Corporation, a next generation synthetic biology company, announced that it has closed a Series F preferred investment round of $150 million, bringing the company’s total capital raised to $509 million. Undisclosed investors accounted for the majority of the round, with current investors, including affiliates of Randal J. Kirk, Intrexon’s Chairman and CEO, […]
In Maryland, Intrexon Corporation and AquaBounty Technologies announced the formation of an exclusive channel collaboration to enhance productivity in aquaculture and develop products that decrease the time to market. AquaBounty will use Intrexon’s UltraVector platform and other technologies to research, develop, manufacture and market products involving key synthetic biology tools to improve the value of […]
In Virginia, Intrexon Corp., a synthetic biology company that utilizes its proprietary technologies to provide control over cellular function, announced that it has entered into a definitive purchase agreement to acquire an approximately 48% interest in AquaBounty Technologies from existing shareholders. ABT is a biotechnology company focused on enhancing the productivity in aquaculture. Under the […]
Two leading biofuels CEOs leave office in one week. Who’s next? Our old friend, Brian Westlake, surfaces to explain the nuances, calm fears, stir troops to action, and detail the real story. So my old pal Brian Westlake calls yesterday, after a long absence, and explains that he’s now investing deeply into industrial biotech. “Bloody […]
